WO2013013864A1 - Process for individualized hair treatment - Google Patents
Process for individualized hair treatment Download PDFInfo
- Publication number
- WO2013013864A1 WO2013013864A1 PCT/EP2012/060041 EP2012060041W WO2013013864A1 WO 2013013864 A1 WO2013013864 A1 WO 2013013864A1 EP 2012060041 W EP2012060041 W EP 2012060041W WO 2013013864 A1 WO2013013864 A1 WO 2013013864A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hair
- specific factor
- factor
- analysis
- individual
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
Definitions
- the invention relates to a method for individualized hair treatment, which allows a targeted cosmetic treatment.
- the procedure should be feasible for the customer quickly and without significant adverse effects (pain, loss of large amounts of hair, time consuming) and also by non-medical personnel (sales assistants, hairdressers, etc.) can be performed.
- the present invention is in a first embodiment, a method for individualized hair treatment, characterized in that a) for hair color to obtain the hair follicle from hairy skin of an individual by plucking wins and b) examining the at least one hair follicle on the expression of at least one hair-specific factor and for extracorporeal analysis of hair follicle cells
- a hair is obtained by plucking to obtain the hair follicle from the hairy skin of an individual. This allows the later extracorporeal analysis of hair follicle cells. Since only one or a few hairs are plucked, this process step is painless for the customer, can be carried out quickly and does not lead to an impairment of the external appearance. This step can be done by a hairdresser, a salesman or by the test person himself.
- the hair or hair follicle cells can then be subjected to the examination. This can be done in a simple handover, but it is also possible to transfer the samples in a suitable packaging and then bring to the examination site or to ship. In this way, sampling and examination can be decoupled spatially and temporally, even a transmission of samples by the customer itself can be done in this way.
- step b) the at least one hair follicle is examined for the expression of at least one hair-specific factor.
- the investigation in step b) is carried out by means of a method which is selected from
- Mass spectrometry in particular Matrix Assisted Laser Desorption Ionization (MALDI) and in particular
- RT-PCR Reverse transcriptase polymerase chain reaction
- the hair-specific factor is a growth factor, preferably HGF and / or KGF and / or SCF and / or C-Met.
- HGF stands for 'hepatocyte growth factor' and KGF for jibroblast growth factor 7 (keratinocyte growth factor) '.
- the signal transduction system of the cytokine HGF ('hepatocyte growth factor') and its receptor MET (c-met, 'hepatocyte growth factor receptor') has a central effect on epithelialmesenchymale interactions and the coordination of participating cells.
- the star cell factor SCF is a protein from the cytokine family that is critically important for the survival, proliferation and differentiation of stem cells, particularly hematopoietic stem cells and progenitor cells.
- the stem cell factor exists in two active forms, a cell membrane-bound and a free variant.
- the free variant is formed from the membrane-bound stem cell factor by metalloproteases. Its effects mediate the stem cell factor by activating the receptor tyrosine kinase c-kit.
- HGF and / or KGF and / or SCF and / or C-Met can be determined immunohistochemically. Their content in the sample provides evidence of the condition of the hair follicle and hair. In general, a high value is considered desirable, i. low levels of HGF and / or KGF and / or SCF and / or C-Met indicate hair damage requiring treatment, so that corresponding hair cosmetic products that increase the levels of HGF and / or KGF and / or SCF and / or C-Met can, are recommended.
- the ATP content can be determined as a hair-specific factor in step b) of the method according to the invention.
- Adenosine triphosphate is a nucleotide consisting of the triphosphate of the nucleoside adenosine (and as such, an energy-rich building block of nucleic acid RNA).
- ATP is primarily the universal form of instantaneous energy available in each cell and, at the same time, an important regulator of energy-providing processes. If necessary, ATP is resynthesized from other energy stores (creatine phosphate, glycogen, fatty acids).
- the ATP molecule consists of an adenine residue, the sugar ribose and three phosphates (a to ⁇ ) in ester (a) or anhydride bond (ß and ⁇ ).
- a high value is desirable, ie low ATP contents suggest that hair damage needs to be treated, so that corresponding hair cosmetic products that can increase the ATP content are recommended.
- the ATP content may be the hair content of the ATP content and / or the average Molar mass of hair keratins are determined.
- step b) of the method according to the invention the representatives derived from the group of keratin-associated proteins (KAPs) can be determined as the hair-specific factor.
- step b) of the method according to the invention recourse to common analysis methods for proteins.
- hair-specific factors which play a role in the pigmentation of the hair shaft and are preferably selected from c-kit, tyrosinase, trp-1, trp-2, MCR can also be determined in step b) of the method according to the invention -1, alpha-MSH, ACTH, GP100).
- hair-specific factors that play a role in hair aging and is preferably selected from RAGE, BAX, Bcl-2, Catalase, beta-galactosidase in step b) of the method according to the invention are possible and preferred.
- the actual value of at least one hair-specific factor is compared with predetermined desired values in step c) of the method according to the invention.
- set values can be determined, for example, by the examination of healthy hair, wherein preferably mean values are formed from a collective.
- the collectives are formed in a particularly uniform and particularly large manner, ie the "base value" is determined from the hair / hair follicles of as many individuals as possible, which share as many properties as possible, age and gender being the most important Procedure leads to the collection of the target values in step c) with a sufficient in terms of age and gender (preferably at least 10, more preferably at least 50 and in particular at least 100 persons) control group.
- control group “female, third decade of life” could be further divided into “female, 25 years” or “female, year of birth xxxx” and possibly even further in “female, 25 years, blond, thin hair” etc ..
- the deviation of the measurement result can be determined. If not only a hair-specific factor is determined, but a majority of these factors, a "hair condition histogram" can be drawn in which individual factors are more or less in need of improvement.
- step d) of the method according to the invention the hair of the individual can be treated with cosmetic agents which improve at least one hair-specific factor.
- the customer can thus be given an individual product recommendation that specifically addresses problematic areas without the customer having to rely on general advertising claims such as "fuller" hair, and the success of the particular cosmetic product can be demonstrated and documented through further analysis after a certain treatment period
- the individual satisfaction of the consumer is thus provided with an objective analysis which is suitable for binding the customer to a manufacturing company and its products.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Cosmetics (AREA)
Abstract
A process for individualized hair treatment, in which e) at least one individual hair is obtained by plucking from hairy skin from a person with retention of the hair follicle for extracorporeal analysis of hair follicle cells and f) the at least one hair follicle is analysed for the expression of at least one hair-specific factor and g) the actual value of at least one hair-specific factor is compared with predefined target values and h) the hair of the person is treated with cosmetic compositions which improve at least one hair-specific factor, allows rapid and painless sampling, external laboratory analysis and communication of the results with product recommendations, and is suitable for distinctly improving customer connection to the business (pharmacy, hair salon, etc.).
Description
"Verfahren zur individualisierten Haarbehandlung" "Method of individualized hair treatment"
Die Erfindung betrifft ein Verfahren zur individualisierten Haarbehandlung, das eine gezielte kosmetische Behandlung ermöglicht. The invention relates to a method for individualized hair treatment, which allows a targeted cosmetic treatment.
Gepflegtes, volles Haar ist ein Verbraucherbedürfnis über alle Kulturen und Altersgrenzen hinweg. Eine schier unendliche Vielfalt haarkosmetischer Produkte will dieses Verbraucherbedürfnis befriedigen, allerdings führt diese Vielfalt auch zu einer Verunsicherung der Verbraucher, welches Produkt für sein Haar und sein gewünschtes Aussehen am besten geeignet ist. Well-groomed, full hair is a consumer need across all cultures and age ranges. An almost infinite variety of hair cosmetic products wants to satisfy this consumer need, but this diversity also leads to uncertainty among consumers, which product is best suited for his hair and his desired appearance.
Es besteht daher der Bedarf, dem Verbraucher jenseits von Marketingversprechen die Auswahl eines speziell auf sein Haar abgestimmten Produktes zu ermöglichen. Bislang sind Untersuchungsmethoden am Individuum der medizinischen Forschung vorbehalten, weil sie entweder zu aufwändig und damit zu teuer sind oder zu viel Probesubstanz (= Haar) benötigen. Eine individuelle, zuverlässige und auch jenseits der Medizin anwendbare Methode, das Haar eines Konsumenten zu beurteilen und anhand der Beurteilung gezielt Produkte anzubieten, existiert im kosmetischen Massenmarkt nicht. There is therefore a need to enable the consumer, beyond marketing promises, to choose a product specially tailored to his hair. So far, research methods on the individual are reserved for medical research because they are either too time-consuming and therefore too expensive or require too much sample substance (= hair). An individual, reliable and also beyond medicine applicable method to judge the hair of a consumer and to offer targeted products based on the assessment does not exist in the cosmetic mass market.
Der vorliegenden Erfindung lag daher die Aufgabe zugrunde, ein Verfahren bereitzustellen, das eine kostengünstige und individuelle Beurteilung des Haarzustands ermöglicht und in Abhängigkeit von der Beurteilung Vorschläge für Produkte unterbreiten kann. Dabei sollte das Verfahren für den Kunden schnell und ohne wesentliche Beeinträchtigungen (Schmerz, Verlust großer Haarmengen, großer Zeitaufwand) durchführbar sein und auch von medizinisch nicht gebildetem personal (Verkäuferinnen, Friseure etc.) durchgeführt werden können. It is an object of the present invention to provide a method which enables a cost-effective and individual assessment of the hair condition and can make proposals for products depending on the evaluation. The procedure should be feasible for the customer quickly and without significant adverse effects (pain, loss of large amounts of hair, time consuming) and also by non-medical personnel (sales assistants, hairdressers, etc.) can be performed.
Es wurde nun gefunden, daß eine schnelle und schmerzlose Probenentnahme, eine externe labormäßige Untersuchung und eine Kommunikation der Ergebnisse mit Produktempfehlungen nicht nur die vorstehend genannten Aufgaben löst, sondern auch geeignet ist, die Kundenbindung an das Geschäft (Drogerie, Friseur etc.) deutlich zu verbessern. It has now been found that a quick and painless sampling, an external laboratory examination and a communication of the results with product recommendations not only solves the above-mentioned tasks, but is also suitable, the customer loyalty to the business (drugstore, hairdressing, etc.) significantly improve.
Gegenstand der vorliegenden Erfindung ist in einer ersten Ausführungsform ein Verfahren zur individualisierten Haarbehandlung, dadurch gekennzeichnet, daß man
a) zur extrakorporalen Analyse von Haarfollikelzellen mindestens ein Haar unter Erhalt des Haarfollikels aus behaarter Haut eines Individuums durch Zupfen gewinnt und b) den mindestens einen Haarfollikel auf die Expression mindestens eines haarspezifischen Faktors untersucht und The present invention is in a first embodiment, a method for individualized hair treatment, characterized in that a) for hair color to obtain the hair follicle from hairy skin of an individual by plucking wins and b) examining the at least one hair follicle on the expression of at least one hair-specific factor and for extracorporeal analysis of hair follicle cells
c) den Ist-Wert mindestens eines haarspezifischen Faktors mit vorgegebenen Sollwerten vergleicht und c) comparing the actual value of at least one hair-specific factor with predetermined target values, and
d) das Haar des Individuums mit kosmetischen Mitteln behandelt, die mindestens einen haarspezifischen Faktor verbessern. d) treating the hair of the individual with cosmetic agents that enhance at least one hair-specific factor.
In einem ersten Schritt des erfindungsgemäßen Verfahrens wird mindestens ein Haar unter Erhalt des Haarfollikels aus behaarter Haut eines Individuums durch Zupfen gewonnen. Hierdurch wird die spätere extrakorporale Analyse von Haarfollikelzellen ermöglicht. Da nur ein oder wenige Haare ausgezupft werden, ist dieser Verfahrensschritt für den Kunden schmerzlos, schnell durchführbar und führt nicht zu einer Beeinträchtigung des äußeren Erscheinungsbildes. Dieser Schritt kann durch einen Friseur, einen Verkäufer oder auch durch den Probanden selbst durchgeführt werden. In a first step of the method according to the invention, at least one hair is obtained by plucking to obtain the hair follicle from the hairy skin of an individual. This allows the later extracorporeal analysis of hair follicle cells. Since only one or a few hairs are plucked, this process step is painless for the customer, can be carried out quickly and does not lead to an impairment of the external appearance. This step can be done by a hairdresser, a salesman or by the test person himself.
Das bzw. die Haare mit den Haarfollikelzellen können anschließend der Untersuchung zugeführt werden. Dies kann in einer einfachen Übergabe erfolgen, es ist aber auch möglich, die Proben in eine geeignete Verpackung zu überführen und dann zum Untersuchungsort zu bringen oder zu versenden. Auf diese Weise können Probeentnahme und -Untersuchung räumlich und zeitlich entkoppelt werden, auch eine Übersendung der Proben durch den Kunden selbst kann auf diese Weise erfolgen. The hair or hair follicle cells can then be subjected to the examination. This can be done in a simple handover, but it is also possible to transfer the samples in a suitable packaging and then bring to the examination site or to ship. In this way, sampling and examination can be decoupled spatially and temporally, even a transmission of samples by the customer itself can be done in this way.
In einem zweiten Schritt der mindestens einen Haarfollikel auf die Expression mindestens eines haarspezifischen Faktors untersucht. In erfindungsgemäß bevorzugten Verfahren führt man die Untersuchung in Schritt b) mittels einer Methode durch, die ausgewählt ist unter In a second step, the at least one hair follicle is examined for the expression of at least one hair-specific factor. In the method preferred according to the invention, the investigation in step b) is carried out by means of a method which is selected from
i. Ein- oder zweidimensionaler Gelelektrophorese i. One- or two-dimensional gel electrophoresis
ii. Affinitätschromatographie ii. affinity
iii. Protein-Protein-Komplexierung in Lösung iii. Protein-protein complexation in solution
iv. ELISA (Enzyme-Iinked Immunosorbent Assay) iv. ELISA (enzyme-linked immunosorbent assay)
v. enzymgekoppelte Stoffwechselassays v. enzyme-linked metabolic assays
vi. Massenspektrometrie, insbesondere Matrix Assistierter Laser Desorptions Ionisation (MALDI) und insbesondere vi. Mass spectrometry, in particular Matrix Assisted Laser Desorption Ionization (MALDI) and in particular
vii. Einsatz von Proteinchips, Northern Blots, vii. Use of protein chips, Northern blots,
viii. Reverse Transkriptase Polymerasekettenreaktion (RT-PCR), viii. Reverse transcriptase polymerase chain reaction (RT-PCR),
ix. RNase-Schutzexperimente, ix. RNase protection experiments
x. Dot-Blots, x. Dot blots,
xi. CDNA-Sequenzierung, xi. CDNA sequencing,
xii. Klon-Hybridisierung, xii. Clone hybridization,
xiii. Differential Display,
xiv. Subtraktive Hybridisierung, xiii. Differential display, xiv. Subtractive hybridization,
xv. cDNA-Fragment-Fingerprinting, xv. cDNA fragment fingerprinting,
xvi. Durchflusszytometrieanalysen, xvi. flow cytometry analysis,
xvii. Serielle Analyse der Genexpression (SAGE) und insbesondere xviii. Einsatz von Nukleinsäurechips, xvii. Serial analysis of gene expression (SAGE) and in particular xviii. Use of nucleic acid chips,
oder mittels geeigneter Kombinationen dieser Methoden. or by suitable combinations of these methods.
In besonders bevorzugten erfindungsgemäßen Verfahren ist der haarspezifische Faktor ein Wachstumsfaktor, vorzugsweise HGF und/oder KGF und/oder SCF und/oder C-Met. In particularly preferred methods according to the invention, the hair-specific factor is a growth factor, preferably HGF and / or KGF and / or SCF and / or C-Met.
Dabei stehen HGF für ,hepatocyte growth factor' und KGF für Jibroblast growth factor 7 (keratinocyte growth factor)'. Das Signaltransduktionssystem des Zytokins HGF (,hepatocyte growth factor') und seines Rezeptors MET (c-met, ,hepatocyte growth factor receptor') hat eine zentrale Wirkung auf epithelialmesenchymale Interaktionen und die Koordination beteiligter Zellen. HGF stands for 'hepatocyte growth factor' and KGF for jibroblast growth factor 7 (keratinocyte growth factor) '. The signal transduction system of the cytokine HGF ('hepatocyte growth factor') and its receptor MET (c-met, 'hepatocyte growth factor receptor') has a central effect on epithelialmesenchymale interactions and the coordination of participating cells.
Der Stern cell factor SCF ist ein Protein aus der Familie der Zytokine, das von entscheidender Bedeutung für das Überleben, die Proliferation und die Differenzierung von Stammzellen, insbesondere Hämatopoietischen Stammzellen und Vorläuferzellen ist. Der Stammzellfaktor existiert in zwei aktiven Formen, einer zellmembrangebundenen und einer freien Variante. Die freie Variante wird aus dem membrangebundenen Stammzellfaktor durch Metalloproteasen gebildet. Seine Effekte vermittelt der Stammzellfaktor durch Aktivierung der Rezeptor-Tyrosinkinase c-Kit. The star cell factor SCF is a protein from the cytokine family that is critically important for the survival, proliferation and differentiation of stem cells, particularly hematopoietic stem cells and progenitor cells. The stem cell factor exists in two active forms, a cell membrane-bound and a free variant. The free variant is formed from the membrane-bound stem cell factor by metalloproteases. Its effects mediate the stem cell factor by activating the receptor tyrosine kinase c-kit.
HGF und/oder KGF und/oder SCF und/oder C-Met können immunohistochemisch bestimmt werden. Ihr Gehalt in der Probe liefert Hinweise auf den Zustand des Haarfollikels und des Haares. Generell gilt dabei ein hoher Wert als erstrebenswert, d.h. niedrige Werte von HGF und/oder KGF und/oder SCF und/oder C-Met lassen auf behandlungsbedürftige Haarschädigungen schließen, so daß entsprechende haarkosmetische Produkte, die den Gehalt an HGF und/oder KGF und/oder SCF und/oder C-Met steigern können, zu empfehlen sind. HGF and / or KGF and / or SCF and / or C-Met can be determined immunohistochemically. Their content in the sample provides evidence of the condition of the hair follicle and hair. In general, a high value is considered desirable, i. low levels of HGF and / or KGF and / or SCF and / or C-Met indicate hair damage requiring treatment, so that corresponding hair cosmetic products that increase the levels of HGF and / or KGF and / or SCF and / or C-Met can, are recommended.
Alternativ oder zusätzlich zu HGF und/oder KGF und/oder SCF und/oder C-Met kann in Schritt b) des erfindungsgemäßen Verfahrens als haarspezifischer Faktor der ATP-Gehalt bestimmt werden. Alternatively or in addition to HGF and / or KGF and / or SCF and / or C-Met, the ATP content can be determined as a hair-specific factor in step b) of the method according to the invention.
Adenosintriphosphat (ATP) ist ein Nukleotid, bestehend aus dem Triphosphat des Nucleosids Adenosin (und als solches ein energiereicher Baustein der Nukleinsäure RNA). Adenosine triphosphate (ATP) is a nucleotide consisting of the triphosphate of the nucleoside adenosine (and as such, an energy-rich building block of nucleic acid RNA).
ATP ist jedoch hauptsächlich die universelle Form unmittelbar verfügbarer Energie in jeder Zelle und gleichzeitig ein wichtiger Regulator energieliefernder Prozesse. ATP wird bei Bedarf aus anderen Energiespeichern (Kreatinphosphat, Glykogen, Fettsäuren) resynthetisiert. Das ATP- Molekül besteht aus einem Adeninrest, dem Zucker Ribose und drei Phosphaten (a bis γ) in Ester- (a) bzw. Anhydridbindung (ß und γ).
Generell gilt dabei ein hoher Wert als erstrebenswert, d.h. niedrige ATP-Gehalte lassen auf behandlungsbedürftige Haarschädigungen schließen, so daß entsprechende haarkosmetische Produkte, die den ATP-Gehalt steigern können, zu empfehlen sind. However, ATP is primarily the universal form of instantaneous energy available in each cell and, at the same time, an important regulator of energy-providing processes. If necessary, ATP is resynthesized from other energy stores (creatine phosphate, glycogen, fatty acids). The ATP molecule consists of an adenine residue, the sugar ribose and three phosphates (a to γ) in ester (a) or anhydride bond (ß and γ). In general, a high value is desirable, ie low ATP contents suggest that hair damage needs to be treated, so that corresponding hair cosmetic products that can increase the ATP content are recommended.
Alternativ oder zusätzlich zu HGF und/oder KGF und/oder SCF und/oder C-Met und/oder zur Bestimmung des ATP-Gehaltes kann in Schritt b) des erfindungsgemäßen Verfahrens als haarspezifischer Faktor der ATP-Gehalt der Keratingehalt und/oder die durchschnittliche Molmasse der Haarkeratine bestimmt werden. Alternatively or in addition to HGF and / or KGF and / or SCF and / or C-Met and / or for determining the ATP content, in step b) of the method according to the invention the ATP content may be the hair content of the ATP content and / or the average Molar mass of hair keratins are determined.
Auch hier sind ein hoher Gehalt an Keratin und hohe Molmassen der Haarkeratine wünschenswert. Alternativ oder zusätzlich lassen sich in Schritt b) des erfindungsgemäßen Verfahrens als haarspezifischer Faktor die aus der Gruppe der Keratin assoziierten Proteine (KAPs) stammenden Vertreter bestimmen. Again, a high content of keratin and high molar masses of hair keratins are desirable. Alternatively or additionally, in step b) of the method according to the invention, the representatives derived from the group of keratin-associated proteins (KAPs) can be determined as the hair-specific factor.
Auch eine Bestimmung der haarspezifischen Faktoren aus der Gruppe der„low sulfur" und/oder „high sulfur" und/oder high glycine / high thyronine" Intermediärfilaamente ist in Schritt b) des erfindungsgemäßen Verfahrens möglich. Hier wie bei allen vorstehend beschriebenen Proteinen kann auf gängige Analyseverfahren für Proteine zurückgegriffen werden. A determination of the hair-specific factors from the group of "low sulfur" and / or "high sulfur" and / or high glycine / high thyronine "intermediary filaments is possible in step b) of the method according to the invention recourse to common analysis methods for proteins.
Parallel oder alternativ zu den bisherigen Bestimmungen können in Schritt b) des erfindungsgemäßen Verfahrens auch haarspezifische Faktoren bestimmt werden, die bei der Pigmentierung des Haarschaftes eine Rolle spielen und vorzugsweise ausgewählt sind aus c-kit, tyrosinase, trp-1 , trp-2, MCR-1 , alpha-MSH, ACTH, GP100). In parallel or as an alternative to the previous determinations, hair-specific factors which play a role in the pigmentation of the hair shaft and are preferably selected from c-kit, tyrosinase, trp-1, trp-2, MCR can also be determined in step b) of the method according to the invention -1, alpha-MSH, ACTH, GP100).
Auch die Bestimmung haarspezifischer Faktoren, die für die Haaralterung eine Roll spielen und vorzugsweise ausgewählt ist aus RAGE, BAX, Bcl-2, Catalse, beta-Galactosidase in Schritt b) des erfindungsgemäßen Verfahrens sind möglich und bevorzugt. The determination of hair-specific factors that play a role in hair aging and is preferably selected from RAGE, BAX, Bcl-2, Catalase, beta-galactosidase in step b) of the method according to the invention are possible and preferred.
In allen vorstehend genannten Fällen und unabhängig davon welcher und wie viele haarspezifische Faktoren bestimmt werden, wird in Schritt c) des erfindungsgemäßen Verfahrens der Ist-Wert mindestens eines haarspezifischen Faktors mit vorgegebenen Sollwerten verglichen. In all cases mentioned above and regardless of which and how many hair-specific factors are determined, the actual value of at least one hair-specific factor is compared with predetermined desired values in step c) of the method according to the invention.
Diese Sollwerte lassen sich beispielsweise durch die Untersuchung gesunder Haare ermitteln, wobei bevorzugt Mittelwerte aus einem Kollektiv gebildet werden. Besonders bevorzugt werden die Kollektive dabei besonders einheitlich und besonders groß gebildet, d.h. der„Basiswert" wird aus den Haaren/Haarfollikeln möglichst vieler Individuen ermittelt, die möglichst viele Eigenschaften miteinander teilen, wobei dem Alter und dem Geschlecht die größte Bedeutung zukommt. In erfindungsgemäß bevorzugten Verfahren führt man die Erhebung der Sollwerte in Schritt c) mit einer in Bezug auf das Alter und das Geschlecht ausreichend großen (vorzugsweise mindestens
10, besonders bevorzugt mindestens 50 und insbesondere mindestens 100 Personen) Kontrollgruppe durch. These set values can be determined, for example, by the examination of healthy hair, wherein preferably mean values are formed from a collective. Particularly preferably, the collectives are formed in a particularly uniform and particularly large manner, ie the "base value" is determined from the hair / hair follicles of as many individuals as possible, which share as many properties as possible, age and gender being the most important Procedure leads to the collection of the target values in step c) with a sufficient in terms of age and gender (preferably at least 10, more preferably at least 50 and in particular at least 100 persons) control group.
Ganz besonders bevorzugt werden noch weitere Spezifizierungen/Gruppierungen eingeführt und die Grenzen möglichst eng gesteckt. So könnte eine Kontrollgruppe „weiblich, drittes Lebensjahrzehnt" weiter aufgeteilt werden in„weiblich, 25 Jahre" oder„weiblich, Geburtsjahrgang xxxx" und gegebenenfalls noch weiter in„weiblich, 25 Jahre, blond, dünnes Haar" usw.. Most particularly, further specifications / groupings are introduced and the limits set as narrow as possible. Thus, a control group "female, third decade of life" could be further divided into "female, 25 years" or "female, year of birth xxxx" and possibly even further in "female, 25 years, blond, thin hair" etc ..
Durch geeignete Wahl der Kontrollgruppe und der in dieser Kontrollgruppe ermittelten Werte für die einzelnen haarspezifischen Faktoren kann die Abweichung des Messergebnisses ermittelt werden. Wird nicht nur ein haarspezifischer Faktor bestimmt, sondern eine Mehrzahl dieser Faktoren, kann ein „Histogramm des Haarzustandes" gezeichnet werden, in dem einzelne Faktoren mehr oder weniger verbesserungswürdig sind. By a suitable choice of the control group and the values determined in this control group for the individual hair-specific factors, the deviation of the measurement result can be determined. If not only a hair-specific factor is determined, but a majority of these factors, a "hair condition histogram" can be drawn in which individual factors are more or less in need of improvement.
Auf dieser Datenlage kann dann in Schritt d) des erfindungsgemäßen Verfahrens das Haar des Individuums mit kosmetischen Mitteln behandelt werden, die mindestens einen haarspezifischen Faktor verbessern. Dem Kunden kann somit eine individuelle Produktempfehlung ausgesprochen werden, die gezielt problematische Bereiche adressiert, ohne daß sich der Kunde auf allgemeine Werbeaussagen wie „fülligeres" Haar verlassen müsste. Zudem kann der Erfolg des jeweiligen Kosmetikums durch eine weitere Analyse nach einer bestimmten Behandlungszeit aufgezeigt und dokumentiert werden. Dem individuellen Zufriedenheitsgefühl des Verbrauchers wird damit eine objektive Analyse zur Seite gestellt, die geeignet ist, dem Kunden an eine Herstellfirma und ihre Produkte zu binden.
On this data basis, in step d) of the method according to the invention, the hair of the individual can be treated with cosmetic agents which improve at least one hair-specific factor. The customer can thus be given an individual product recommendation that specifically addresses problematic areas without the customer having to rely on general advertising claims such as "fuller" hair, and the success of the particular cosmetic product can be demonstrated and documented through further analysis after a certain treatment period The individual satisfaction of the consumer is thus provided with an objective analysis which is suitable for binding the customer to a manufacturing company and its products.
Claims
1. Verfahren zur individualisierten Haarbehandlung, dadurch gekennzeichnet, daß man 1. A method for individualized hair treatment, characterized in that one
a) zur extrakorporalen Analyse von Haarfollikelzellen mindestens ein Haar unter Erhalt des Haarfollikels aus behaarter Haut eines Individuums durch Zupfen gewinnt und b) den mindestens einen Haarfollikel auf die Expression mindestens eines haarspezifischen Faktors untersucht und a) for hair color to obtain the hair follicle from hairy skin of an individual by plucking wins and b) examining the at least one hair follicle on the expression of at least one hair-specific factor and for extracorporeal analysis of hair follicle cells
c) den Ist-Wert mindestens eines haarspezifischen Faktors mit vorgegebenen Sollwerten vergleicht und c) comparing the actual value of at least one hair-specific factor with predetermined target values, and
d) das Haar des Individuums mit kosmetischen Mitteln behandelt, die mindestens einen haarspezifischen Faktor verbessern. d) treating the hair of the individual with cosmetic agents that enhance at least one hair-specific factor.
2. Verfahren nach Anspruch 1 , dadurch gekennzeichnet, daß man die Untersuchung in Schritt b) mittels einer Methode durchführt, die ausgewählt ist unter 2. The method according to claim 1, characterized in that one carries out the investigation in step b) by means of a method which is selected from
i. Ein- oder zweidimensionaler Gelenktrophorese i. One- or two-dimensional gel electrophoresis
ii. Affinitätschromatographie ii. affinity
iii. Protein-Protein-Komplexierung in Lösung iii. Protein-protein complexation in solution
iv. ELISA (Enzyme-Iinked Immunosorbent Assay) iv. ELISA (enzyme-linked immunosorbent assay)
v. enzymgekoppelte Stoffwechselassays v. enzyme-linked metabolic assays
vi. Massenspektrometrie, insbesondere Matrix Assistierter Laser Desorptions Ionisation (MALDI) und insbesondere vi. Mass spectrometry, in particular Matrix Assisted Laser Desorption Ionization (MALDI) and in particular
vii. Einsatz von Proteinchips, Northern Blots, vii. Use of protein chips, Northern blots,
viii. Reverse Transkriptase Polymerasekettenreaktion (RT-PCR), viii. Reverse transcriptase polymerase chain reaction (RT-PCR),
ix. RNase-Schutzexperimente, ix. RNase protection experiments
x. Dot-Blots, x. Dot blots,
xi. CDNA-Sequenzierung, xi. CDNA sequencing,
xii. Klon-Hybridisierung, xii. Clone hybridization,
xiii. Differential Display, xiii. Differential display,
xiv. Subtraktive Hybridisierung, xiv. Subtractive hybridization,
xv. cDNA-Fragment-Fingerprinting, xv. cDNA fragment fingerprinting,
xvi. Durchflusszytometrieanalysen, xvi. flow cytometry analysis,
xvii. Serielle Analyse der Genexpression (SAGE) und insbesondere xviii. Einsatz von Nukleinsäurechips, xvii. Serial analysis of gene expression (SAGE) and in particular xviii. Use of nucleic acid chips,
oder mittels geeigneter Kombinationen dieser Methoden. or by suitable combinations of these methods.
3. Verfahren nach einem der Ansprüche 1 oder 2, dadurch gekennzeichnet, daß der haarspezifische Faktor ein Wachstumsfaktor, vorzugsweise HGF und/oder KGF und/oder SCF und/oder C-Met ist. 3. The method according to any one of claims 1 or 2, characterized in that the hair-specific factor is a growth factor, preferably HGF and / or KGF and / or SCF and / or C-Met.
4. Verfahren nach einem der Ansprüche 1 bis 3, dadurch gekennzeichnet, daß der haarspezifische Faktor der ATP-Gehalt ist. 4. The method according to any one of claims 1 to 3, characterized in that the hair-specific factor is the ATP content.
5. Verfahren nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, daß der haarspezifische Faktor der Keratingehalt und/oder die durchschnittliche Molmasse der Haarkeratine ist. 5. The method according to any one of claims 1 to 4, characterized in that the hair-specific factor is the keratin content and / or the average molecular weight of the hair keratins.
6. Verfahren nach einem der Ansprüche 1 bis 5, dadurch gekennzeichnet, daß der haarspezifische Faktor aus der Gruppe der Keratin assoziierten Proteine (KAPs) stammt. 6. The method according to any one of claims 1 to 5, characterized in that the hair-specific factor from the group of keratin-associated proteins (KAPs) is derived.
7. Verfahren nach einem der Ansprüche 1 bis 6, dadurch gekennzeichnet, daß der haarspezifische Faktor aus der Gruppe der„low sulfur" und/oder„high sulfur" und/oder high glycine / high thyronine" Intermediärfilaamente stammt. 7. The method according to any one of claims 1 to 6, characterized in that the hair-specific factor from the group of "low sulfur" and / or "high sulfur" and / or high glycine / high thyronine "Intermediärfilaamente comes.
8. Verfahren nach einem der Ansprüche 1 bis 7, dadurch gekennzeichnet, daß der haarspezifische Faktor bei der Pigmentierung des Haarschaftes eine Rolle spielt und vorzugsweise ausgewählt ist aus c-kit, tyrosinase, trp-1 , trp-2, MCR-1 , alpha-MSH, ACTH, GP100). 8. The method according to any one of claims 1 to 7, characterized in that the hair-specific factor in the pigmentation of the hair shaft plays a role and is preferably selected from c-kit, tyrosinase, trp-1, trp-2, MCR-1, alpha MSH, ACTH, GP100).
9. Verfahren nach einem der Ansprüche 1 bis 8, dadurch gekennzeichnet, daß der haarspezifische Faktor für die Haaralterung eine Roll spielt und vorzugsweise ausgewählt ist aus RAGE, BAX, Bcl-2, Catalse, beta-Galactosidase. 9. The method according to any one of claims 1 to 8, characterized in that the hair-specific factor for hair aging plays a roll and is preferably selected from RAGE, BAX, Bcl-2, Catalse, beta-galactosidase.
10. Verfahren nach einem der Ansprüche 1 bis 9, dadurch gekennzeichnet, daß man die Erhebung der Sollwerte in Schritt c) mit einer in Bezug auf das Alter und das Geschlecht ausreichend großen (vorzugsweise mindestens 10, besonders bevorzugt mindestens 50 und insbesondere mindestens 100 Personen) Kontrollgruppe durchführt. 10. The method according to any one of claims 1 to 9, characterized in that the collection of the target values in step c) with a sufficiently large in age and sex (preferably at least 10, more preferably at least 50 and in particular at least 100 people ) Controls.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE201110079661 DE102011079661A1 (en) | 2011-07-22 | 2011-07-22 | Method of individualized hair treatment |
DE102011079661.4 | 2011-07-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013013864A1 true WO2013013864A1 (en) | 2013-01-31 |
Family
ID=46229450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2012/060041 WO2013013864A1 (en) | 2011-07-22 | 2012-05-29 | Process for individualized hair treatment |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102011079661A1 (en) |
WO (1) | WO2013013864A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2544834A (en) * | 2015-06-09 | 2017-05-31 | Waters Technologies Corp | Profile diagnositcs in personalized dermatology, dermatopathology and cosmetics |
GB2545521A (en) * | 2015-06-09 | 2017-06-21 | Waters Technologies Corp | Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004059002A2 (en) * | 2002-12-20 | 2004-07-15 | Henkel Kommanditgesellschaft Auf Aktien | Method for determining the homeostasis of hairy skin |
WO2006097205A2 (en) * | 2005-03-14 | 2006-09-21 | Henkel Kommanditgesellschaft Auf Aktien | Method for conducting extracorporeal analysis of hair follicle cells |
FR2939198A1 (en) * | 2008-12-02 | 2010-06-04 | Oreal | Non-therapeutic process, useful for evaluating hair condition, comprises taking hair follicles, analyzing the content of at least analyte having e.g. taurine, and comparing the content obtained after analyzing step with reference content |
-
2011
- 2011-07-22 DE DE201110079661 patent/DE102011079661A1/en not_active Withdrawn
-
2012
- 2012-05-29 WO PCT/EP2012/060041 patent/WO2013013864A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004059002A2 (en) * | 2002-12-20 | 2004-07-15 | Henkel Kommanditgesellschaft Auf Aktien | Method for determining the homeostasis of hairy skin |
WO2006097205A2 (en) * | 2005-03-14 | 2006-09-21 | Henkel Kommanditgesellschaft Auf Aktien | Method for conducting extracorporeal analysis of hair follicle cells |
FR2939198A1 (en) * | 2008-12-02 | 2010-06-04 | Oreal | Non-therapeutic process, useful for evaluating hair condition, comprises taking hair follicles, analyzing the content of at least analyte having e.g. taurine, and comparing the content obtained after analyzing step with reference content |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2544834A (en) * | 2015-06-09 | 2017-05-31 | Waters Technologies Corp | Profile diagnositcs in personalized dermatology, dermatopathology and cosmetics |
GB2545521A (en) * | 2015-06-09 | 2017-06-21 | Waters Technologies Corp | Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics |
US9881777B2 (en) | 2015-06-09 | 2018-01-30 | Waters Technologies Corporation | Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics |
GB2545521B (en) * | 2015-06-09 | 2018-11-07 | Waters Technologies Corp | Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics |
GB2565238A (en) * | 2015-06-09 | 2019-02-06 | Waters Technologies Corp | Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics |
US10228361B2 (en) | 2015-06-09 | 2019-03-12 | Waters Technologies Corporation | Profile diagnostics in personalized dermatology, dermatopathology and cosmetics |
US10410846B2 (en) | 2015-06-09 | 2019-09-10 | Waters Technologies Corporation | Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics |
Also Published As
Publication number | Publication date |
---|---|
DE102011079661A1 (en) | 2013-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wood | The importance of hydration and DNA conformation in interpreting infrared spectra of cells and tissues | |
DE10100127A1 (en) | Procedure for determining the homeostasis of the skin | |
Pudney et al. | Confocal Raman spectroscopy of whole hairs | |
Huang et al. | Investigation on microecology of hair root fungi in androgenetic alopecia patients | |
WO2013013864A1 (en) | Process for individualized hair treatment | |
DE10260931B4 (en) | Method for determining the homeostasis of hairy skin | |
Barth | How hairy are hirsute women? | |
Gaines et al. | Reimagining Hair Science: A New Approach to Classify Curly Hair Phenotypes via New Quantitative Geometric and Structural Mechanical Parameters | |
Nikiforidis et al. | Mechanical parameters of human hair: possible application in the diagnosis and follow-up of hair disorders | |
Iobst et al. | Biotechnology in skin care (I): Overview | |
JP5535571B2 (en) | Method for evaluating skin turnover and its use | |
Pinto et al. | Dermoscopy is the crucial step for proper outcome prospection when treating androgenetic alopecia with the Regenera® protocol: a score proposal | |
CN111132615A (en) | Evaluation method, selection method, evaluation support tool, and screening method | |
DE10260928A1 (en) | Method for the determination of markers of human facial skin | |
DE102011119953A1 (en) | Individualized skin treatment comprises e.g. applying and removing adhesive tape on skin surface, obtaining adherent biological material, determining expression and/or activity of differentiation marker, and treating with cosmetic products | |
Serrano-Pertierra et al. | Extracellular vesicles: from biology to biomedical applications | |
Cornwell et al. | Defying damage: understanding breakage in Afro-textured hair | |
DE10047217A1 (en) | Process for the production of ribonucleic acid (RNA) | |
Nikiforidis et al. | A method for the determination of viscoelastic parameters of human hair in relation to its structure | |
Bhattacharjee et al. | Hot topics in pediatric dermatology | |
Saleh et al. | Effect of Protein'Hair Straightener | |
Umehara et al. | Effects of antimicrobial peptide LL-37 on expression of natural moisturizing factor-generating proteases in epidermal keratinocytes | |
El-Refaey et al. | Evaluation of Serum levels of epidermal growth factor (EGF) in Patients with alopecia areata | |
McPherson et al. | Assessing Neurotoxicant-Induced Inflammation in the Central Nervous System: Cytokine mRNA with Immunostaining of Microglia Morphology | |
Palmieri et al. | Noninvasive Genetic Testing: Adhesive Patch-Based Skin Biopsy and Buccal Swab |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12726384 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12726384 Country of ref document: EP Kind code of ref document: A1 |